nference - About the company
nference is a series C company based in Cambridge (United States), founded in 2013 by Murali Aravamudan. It operates as a Provider of an AI platform for clinical data analysis and insights. nference has raised $134M in funding from investors like Mayo Clinic, Mayo Clinic Ventures and Matrix, with a current valuation of $*****. The company has 744 active competitors, including 85 funded and 45 that have exited. Its top competitors include companies like Ovation, Kyruus Health and Truveta.
Company Details
Provider of an AI platform for clinical data analysis and insights. The platform facilitates patient cohort design, exploration of patient journeys, and data annotation for model development. It also offers a data science workbench and supports anatomical computations. It aims to unlock healthcare datas potential while ensuring patient privacy.
- Website
- nference.com
- Social
- Email ID
- *****@nference.net
- Registered Address
- Stoughton, Massachusetts
Key Metrics
Founded Year
2013
Location
Cambridge, United States
Stage
Series C
Total Funding
$134M in 4 rounds
Latest Funding Round
Post Money Valuation
$***** as on Dec 15, 2020
Investors
Ranked
11th among 744 active competitors
Employee Count
315 as on Sep 30, 2026
Similar Companies
Legal entities associated with nference
nference is associated with 4 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Nference, Inc. CIN: 20211297588 , United States, Active | Mar 25, 2021 | - | - | - |
NFERENCE, INC. CIN: 5346328 , United States, Active | May 23, 2018 | - | - | - |
NFERENCE LABS PRIVATE LIMITED CIN: U72900KA2018FTC113334 , India, Active | May 22, 2018 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 321 (As on Oct 31, 2024) | |
Nference, Inc. CIN: 461833049 , United States, Active | Jan 21, 2013 | - | 92 (As on Dec 31, 2024) | - |
Sign up to download nference's company profile
nference's funding and investors
nference has raised a total funding of $134M over 4 rounds. Its first funding round was on Jun 06, 2018. nference has 5 institutional investors.
Here is the list of recent funding rounds of nference:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 21, 2022 | 9884545 | Series C | 2193673 | 4155263 | 6094112 | 7766684 |
Dec 15, 2020 | 1182654 | Series C | 2124729 | 9730958 | 9993596 | |
Jan 08, 2020 | 8540462 | Series B | 4951421 | 9820882 |
Access funding benchmarks and valuations. Sign up today!View details of nference's funding rounds and investors
nference's founders and board of directors
Founder? Claim ProfileThe founders of nference is Murali Aravamudan. Murali Aravamudan is the CEO of nference.
Here are the details of nference's key team members:
- Murali Aravamudan: Co-Founder & CEO of nference. Contact Info: 1 email address
View details of nference's Founder profiles and Board Members
nference's employee count trend
nference has 315 employees as of Sep 26. Here is nference's employee count trend over the years:
Uncover nference's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
nference's Competitors and alternates
Top competitors of nference include Ovation, Kyruus Health and Truveta. Here is the list of Top 10 competitors of nference, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Ovation 2009, Cambridge (United States), Series B | Provider of a cloud-based laboratory information and data management platform for researchers and clinicians | $33.3M | 69/100 | |
2nd |  Kyruus Health 2010, Boston (United States), Acquired | Provider of software solutions for clinical decision making | $196M | 68/100 | |
3rd |  Truveta 2020, Seattle (United States), Series C | Provider of healthcare data platform for learning services | $515M | 65/100 | |
4th | Carta Healthcare 2017, San Mateo (United States), Series B | Provider of an AI platform for clinical data management solutions | $80.6M | 64/100 | |
5th | Abacus Insights 2017, New York City (United States), Series C | Provider of data management solutions | $94.9M | 63/100 | |
6th |  OM1 2015, Cambridge (United States), Series C | Platform that enables providers to manage CMS CJR bundle for value-based care | $171M | 62/100 | |
7th | Provider of an AI-based medical data management and mining platform for the healthcare industry | $200M | 62/100 | ||
8th |  Seg Med 2019, Stanford (United States), Series A | Provider of AI based clinical data management software and services for researchers | $17.7M | 61/100 | |
9th |  Motivity 2002, Seattle (United States), Series A | Provider of software for collecting data for clinics | $38M | 60/100 | |
10th | InterSystems 1978, Cambridge (United States), Acquired | Cloud based database management software | - | 59/100 | |
11th |  nference 2013, Cambridge (United States), Series C | Provider of an AI platform for clinical data analysis and insights | $134M | 55/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on nference's competitors? Click here to see the top ones
nference's Investments and acquisitions
nference has acquired 2 companies including Predible and Spectral Insights. nference has not made any investments as of now.Reports related to nference
Here is the latest report on nference's sector:
News related to nference
Filter this listMedia has covered nference for a total of 2 events in the last 1 year, 1 of them has been about company updates.
•
•
•
Valo Health and nference Announce Long-term Partnership to Accelerate Human-Centric Drug Discovery and DevelopmentBusiness Wire•Mar 18, 2025•Valo Health, nference
•
nference Establishes AI Research Partnership with Parabilis Medicines in Colorectal CancerBusiness Wire•Nov 12, 2024•nference, Parabilis Medicines
•
Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advancesnference•Oct 24, 2024•Avadel Pharmaceuticals, nference, Predible
•
nference Establishes AI Initiative with Takeda to Advance Precision Medicine in Inflammatory Bowel Diseasenference•Jul 17, 2024•Predible, nference, Takeda
•
Mankind Pharma in licensing pact with Takeda to market acidity drug Vonoprazan in IndiaIndiatimes•Jul 16, 2024•Mankind, Takeda, nference
•
“Systems And Methods For Computing With Private Healthcare Data” in Patent Application Approval Process (USPTO 20240119176): Nference IncInsuranceNewsNet•May 02, 2024•nference
•
“Systems And Methods For Computing With Private Healthcare Data” in Patent Application Approval Process (USPTO 20240062860): Nference Inc.InsuranceNewsNet•Mar 12, 2024•nference
•
nference Announces Multi-Year Funding from Global Foundation to Advance Health EquityBusiness Wire•Feb 06, 2024•nference
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about nference
Explore our recently published companies
- Bitcoin Layers - Acquired company
- HFTS - Switzerland based, Public company
- PT STBC - Pasuruan based, Acquired company
- Ofar - Reykjavik based, Acquired company
- Vidya Therapeutics - Acquired company
- Kids Bowel Bladder - Acquired company
